Susanna Fletcher Greer: Unlocking the Power of Data to Improve Cancer Treatments
Susanna Fletcher Greer, Chief Scientific Officer at The V Foundation for Cancer Research, shared a post on LinkedIn:
“Unlocking the Power of Data to Improve Cancer Treatments
Imagine if oncologists could predict which cancer patients would respond best to a particular treatment? That would be incredible, right? It would save time, money, and most importantly: lives. Well, that’s exactly what the V Foundation funded researchers are working toward with immune checkpoint blockade (ICB) therapies, a type of treatment that helps the immune system recognize and attack cancer. While ICB has been life-changing for some patients, it doesn’t work for everyone, and we are still trying to understand why.
To solve this puzzle, the V Foundation funded grantee Dr. Marcin Cieslik at the University of Michigan Rogel Cancer Center and others have turned to a powerful technique called single-cell RNA sequencing, (scRNA-seq). This cutting-edge tool allows researchers to study individual cancer cells in great detail. However, previous studies have been limited by small sample sizes and very complex data that are difficult for many researchers to analyze.
To address this challenge, Dr. Cieslik and team have compiled data from over 220 cancer patients across nine different cancer types, creating a massive, easy-to-use resource that can help ALL researchers better understand how cancer cells respond to ICB therapy.
This new dataset includes over 90,000 cancer cells and 265,000 other cell types, providing an unprecedented look at how different types of cancer react to immunotherapy.
Importantly, the team has also developed a user-friendly tool so that researchers, whether they are experts in computational biology or not, can explore the data with ease.
By sharing this resource freely, they are accelerating discoveries that could lead to more effective cancer treatments in the future.
This work highlights the power of collaboration and the importance of funding cancer research. By investing in studies like this one, the V Foundation is ensuring that ALL cancer researchers, whether funded by the V Foundation or not, have the tools and knowledge needed to develop better treatments and improve patient outcomes.
Cancer research is not just about what happens in the lab, it’s about what we DO with that research, and ultimately, about giving every patient the best possible chance at survival. Your support of the V Foundation helps us make the impossible, possible.
Find the Cieslik lab at Marcin Cieslik Profile | University of Michigan and read the paper.”
Authors: Mahnoor N. Gondal, Marcin Cieslik & Arul M. Chinnaiyan
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023